Advertisement
We invite authors to submit original research and review articles that focus on or illuminate aspects of the epidemiology, clinical, diagnostics, therapeutics and prevention of Viral Emerging and Re-emerging Infectious Diseases.
Guest Editor - Alfonso J. Rodriguez-Morales
Annals of Clinical Microbiology and Antimicrobials considers novel manuscripts on all aspects of clinical microbiology, infectious diseases and antimicrobials. They must include epidemiological and/or clinical information about isolates, and be of more than regional relevance.
Submitted manuscripts can report on: any aspect of diagnosis of infectious diseases; biological aspects of infectious diseases; case management and antimicrobial treatment; antibiotic development and antimicrobial resistance
Triple combination antibiotic therapy for carbapenemase-producing Klebsiella pneumoniae: a systematic review
David M. Jacobs, M. Courtney Safir, Dennis Huang, Faisal Minhaj, Adam Parker and Gauri G. Rao
Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes
Yuhui Xu, Jianan Wu, Sha Liao and Zhaogang Sun
Diagnostic testing for Legionnaires’ disease
David M. Pierre, Julianne Baron, Victor L. Yu and Janet E. Stout
The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
Jian Wang, Yaping Pan, Jilu Shen and Yuanhong Xu
Pandemics, pathogenicity and changing molecular epidemiology of cholera in the era of global warming
Fazle Rabbi Chowdhury, Zannatun Nur, Nazia Hassan, Lorenz von Seidlein and Susanna Dunachie
Hakan Leblebicioglu, Editor-in-Chief
Professor Leblebicioglu is the former head of the Department of Infectious Diseases and Clinical Microbiology at Ondokuz Mayis University Medical School in Turkey and working at Samsun Liv Hospital, Turkey. He is currently a Fellow of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), a founding member and Honorary Chief of ESCMID Study Group for Infections in Travelers and Migrants (ESGITM) and also a member of the Study Group for Viral Hepatitis (ESGVH).
He has authored 162 publications in peer-reviewed international medical journals (H index is 31 in Web of Science), mainly in Crimean Congo hemorrhagic fever, viral hepatitis and healthcare associated infections. He has conducted workshops and courses in the area of effective communication, presentation skills, proposal and manuscript writing.
Advertisement
Speed
111 days to first decision for reviewed manuscripts only
52 days to first decision for all manuscripts
173 days from submission to acceptance
11 days from acceptance to publication
Citation Impact
3.924 - 2-year Impact Factor
3.032 - 5-year Impact Factor
1.367 - Source Normalized Impact per Paper (SNIP)
1.060 - SCImago Journal Rank (SJR)
Usage
299,710 Downloads
192 Altmetric Mentions
Advertisement
